Investing.com — As the number of seasonal flu cases across the country increases, vaccine manufacturers continue to see gains in premarket trading.
Moderna (NASDAQ:MRNA) and Novavax (NASDAQ:NVAX), two vaccine developers, have advanced in the premarket session, with Moderna gaining 4.9% and Novavax increasing by 6.7%.
Other vaccine stocks to monitor include CureVac, BioNTech (NASDAQ:BNTX) and Pfizer (NYSE:PFE). In addition to vaccine developers, pharmacy chains and hospital firms are also on the watchlist.
Among these are Walgreens and CVS Health (NYSE:CVS), as well as HCA Healthcare (NYSE:HCA). As the flu season progresses, these companies could see changes in their stock performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
